CTOs on the Move

Urovant

www.urovant.com

 
We aim to advance urologic patient care through bold innovation, based on diversity of thought, openness to new ideas, adaptation to change, integrity and compassion. We develop innovative therapies and participate in exceptional licensing opportunities. Our goal is to be the leading specialty company: recognized and trusted by patients and providers for our commitment to urology. Urologic conditions can have a major impact on daily life, with those affected often suffering in silence as their conditions are overlooked, misunderstood or not adequately treated.
  • Number of Employees: 250-1000
  • Annual Revenue: $10-50 Million
  • www.urovant.com
  • 5151 California Avenue Suite 250
    Irvine, CA USA 92617
  • Phone: 949.226.6029

Executives

Name Title Contact Details

Similar Companies

Windstone Medical Packaging Inc

At WindStone Medical, we measure our success by our customers' satisfaction. WindStone has evolved from a dedicated cardiovascular open heart surgical pack company to a national provider of a complete line of multi-specialty surgical packs. For over a

Smart Choice MRI

At Smart Choice MRI, we put your comfort and convenience first. That doesn`t just mean giving you a scan using advanced GE technology and the expert interpretation by a Cleveland Clinic radiologist, for a fraction of what it would cost at a hospital. That means working with your schedule, offering early morning, evening, and weekend appointments, and doing whatever we can to make your scan a relaxing, comfortable experience.

Midwestern Connecticut Council on Alcoholism (MCCA)

Midwestern Connecticut Council on Alcoholism (MCCA) is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Midwestern Connecticut Council on Alcoholism (MCCA) is based in Danbury, CT. You can find more information on Midwestern Connecticut Council on Alcoholism (MCCA) at www.mccaonline.com

Access Case Management Services of Georg

Access Case Management Services of Georg is a Savannah, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Envisia Therapeutics

Envisia Therapeutics, formed by Liquidia Technologies in 2013, is a privately held biotechnology company focused on the development of novel ocular therapies. Envisia is leveraging the unique and powerful properties of the PRINT® platform to develop therapies for a variety of ocular conditions, the most advanced of which is ENV515, for the treatment of glaucoma. ENV515 is a novel extended-release formulation of a prostaglandin analogue formulation. It has the potential to significantly limit disease progression and vision loss through improved product performance and patient compliance. Envisia is located in Research Triangle Park, North Carolina.